Holding AGNG?
Track your performance easily

AGNG Price & Analysis

AGNG ETF Chart & Stats

Day’s Range0 - 0
52-Week Range24.41 - 31.80
Previous Close31.09
VolumeN/A
Average Volume (3M)4.95K
AUMN/A
NAVN/A
Expense RatioN/A
Holdings CountN/A
Beta0.72
Inception DateN/A
0.23 (―)
Shares Outstanding2,310,089
Standard Deviation0.05
10 Day Avg. Volume12,964
30 Day Avg. Volume4,948
Alpha-0.00116

(AGNG) Fund Flow Chart

(AGNG) 1 year Net Flows: ―

AGNG ETF FAQ

What was N/A’s price range in the past 12 months?
N/A lowest ETF price was 24.41 and its highest was 31.80 in the past 12 months.
    What is the AUM of N/A?
    Currently, no data Available
    Is N/A overvalued?
    Not enough analysts have published a price target to calculate whether the price is overvalued.
    Does N/A pay dividends?
    N/A pays a Semiannually dividend of 0.1 which represents an annual dividend yield of N/A. See more information on N/A dividends here
      How many shares outstanding does N/A have?
      N/A has 2,310,089 shares outstanding.
        Which hedge fund is a major shareholder of N/A?
        Currently, no hedge funds are holding shares in AGNG

        Top 10 Holdings

        Name
        Weight %
        Amgen Inc
        3.53%
        Welltower, Inc.
        3.45%
        Chugai Pharmaceutical Co
        3.39%
        Regeneron Pharmaceuticals
        3.33%
        ALC
        Alcon
        3.25%
        RO
        Roche Holding Ltd
        3.23%
        AstraZeneca
        3.20%
        Abbvie
        3.14%
        Boston Scientific
        3.09%
        Johnson & Johnson
        3.07%
        Total32.70%

        ETF Description

        Sector
        N/A
        Asset Class
        N/A
        Region
        Issuer
        Index Tracked
        Ticker Symbol
        AGNG
        Popular ETFs
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis